扫码关注科兴官方微信号“疫苗之益”

Influenza Vaccine (Split Virion), Inactivated - Anflu®
Influenza Vaccine (Split Virion), Inactivated - Anflu®

fluenza Vaccine (Split Virion), Inactivated, Quadrivalent

Pandemic Influenza Vaccine (Inactivated, Adjuvanted)- Panflu®

H1N1 Influenza A Vaccine (Split Virion), Inactivated - Panflu.1®

Sinovac has the most comprehensive portfolio of influenza vaccines

Anflu® was launched in 2006 as the first preservative-free trivalent influenza vaccine in China

The QIV vaccine, independently developed by Sinovac, was launched in 2020

The H5N1 Flu Vaccine, Panflu®, the first of its kind in China, was approved for national stockpiling in 2008

The world’s first H1N1 Flu Vaccine, Panfu.1®, was approved for launch in 2009 and used for massive inoculation around the world

The project “Key Technologies for Evaluation of Pandemic Influenza Vaccines and Immunosorbent: Innovation and Application" won first prize at the Science and Technology Awards from the Chinese Pharmaceutical Association in 2010, first prize at Beijing Scientific and Technological Progress Awards in 2010, and the second prize at the National Scientific and Technological Progress Awards in 2011.


MetInfo enterprise content manager system | MetInfo CMS

MetInfo enterprise content manager system | MetInfo CMS

MetInfo enterprise content manager system | MetInfo CMS




Related news
year:
--All--
  • --All--
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
Load more